OncoCyte (OCX) Misses Q1 EPS by 113c

OncoCyte (NASDAQ: OCX) reported Q1 EPS of ($1.13). Revenue for the quarter came in at $180 thousand.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Progress Software completes $400M acquisition of Domo's data platform
• Activist Corvex seeks Whitbread board seat over strategy concerns